This project has emerged from the collective will of the paediatric oncology community in the UK.
It is a testament to the strength and resilience of the UK NHS, our paediatric oncology centres, academic institutions and patient networks.
Our objective is to identify and learn from every case of COVID-19 in paediatric cancer centres across the UK.
PAEDS PROJECT 1
Start date: June 2020
Delivery date: Dec 2020
Cohort: Paediatric cancer patients
Headline findings: “children with haematological malignancies who have not had an allogeneic stem cell transplant are not at greater risk of severe infection with COVID-19 than other children with cancer”
Impact: “. Children with haematological malignancies need not be considered extremely vulnerable and should continue with standard of care therapy without modification attendant on the SARS-CoV-2 pandemic.”
PAEDS PROJECT 2
Start date: Dec 2020
Delivery date: July 2021
Cohort: Paediatric cancer patients
Headline findings: “children with cancer with SARS-CoV-2 infection do not appear at increased risk of severe infection compared to the general paediatric population”
Impact: “Essential to continue safe cancer care for children and young patients with malignancy”